Drug Trial Radar · NCT02160665
Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Nov 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
866
Actual
Start
May 2014
Primary completion
May 2016
Study completion May 2016
Sponsor
- Lead sponsor
- G & W Laboratories Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 11, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the safety and efficacy profiles of Tazarotene Cream, 0.05% and Tazorac® (Tazarotene) Cream, 0.05% in order to demonstrate bioequivalence and to demonstrate the superiority of the 2 active creams over that of the Vehicle (placebo) in the treatment of plaque psoriasis.
Conditions
- Plaque Psoriasis
Interventions
Tazarotene Cream, 0.05%Drug
Tazarotene Cream, 0.05% (G \& W Laboratories, Inc.)
VehicleDrug
Vehicle of Test product (G \& W Laboratories, Inc.)
Reference: Tazorac Cream, 0.05%Drug
Reference: Tazorac (tazarotene) Cream, 0.05% (Allergan, Inc.)
Primary outcomes
What the sponsor says the trial is designed to measure.
- primary efficacy endpointTime frame: Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Altman Dermatology Associates
Arlington Heights, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.